n CME : Your SA Journal of CPD - Nuclear medicine in oncology 2 : breast, prostate, and cervical cancer, melanoma, and neuro-endocrine tumours




For 40 years a bone scan has been one of the most sensitive methods for the evaluation of the presence and localisation of skeletal metastases resulting from breast and prostate cancer. The accuracy of conventional bone scans is about 80%. The use of single photon emission computed tomography (SPECT) increases the accuracy to 88%, and by combining SPECT with computed tomography (CT) (SPECT/CT) the overall accuracy rises to 92%.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error